<DOC>
	<DOCNO>NCT02581371</DOCNO>
	<brief_summary>The aim present clinical phase IV study estimate influence Cerebrolysin combination standard therapy dynamic recovery paretic upper limb patient acute ischemic stroke . Each patient participate study 176-190 day ( approximately 6 month ) . The estimate duration study 2 year .</brief_summary>
	<brief_title>Comprehensive Reparative Therapy Ischemic Stroke COMplex Repair Ischemic Stroke-Arm</brief_title>
	<detailed_description>Rehabilitation program drug therapy stroke aim , primarily , stimulation process neuroplasticity . After screen procedure eligible patient get randomize 1 2 group : either group standard therapy combination Cerebrolysin infusion , group standard therapy combination placebo infusion . The therapy consist 3 consecutive period : 1. st - 10 day daily infusion Cerebrolysin / placebo ; 2. nd - 7 day break ; 3. - 10 day daily infusion Cerebrolysin / placebo . All participant attend 7 Visits study ( Visits 0 , 1-6 ) 2 site respectively : 1. st - clinical center # 1 - Sverdlovsk Regional Clinical Hospital # 1 , Ekaterinburg 2. nd - clinical center # 2 - Clinical Institute Brain , Ekaterinburg . Patients transfer 1st site 2nd one moment time Visit 2 Visit 3 . Patients undergo traditional laboratory clinical examination procedure several specific one scale NIHSS , modify Rankin scale , Barthel index , hand Frenchy assessment . All hand Frenchy assessment videotape late evaluation authorize researcher . All participant undergo procedure navigational transcranial magnetic stimulation brain NBS eXimia Nexstim use individual 3D brain model create Visit 0 MRI result basis . Neither patient doctor know whether receive investigational drug placebo .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Cerebrolysin</mesh_term>
	<criteria>Inclusion criterion : 1 . A signed patient inform consent ; 2 . Men woman age 45 year 75 year , inclusive ; 3 . Confirmed ( clinically MRI brain ) diagnosis acute ischemic stroke basin middle cerebral artery ; 4 . The severity stroke 5 24 point scale NIHSS ; 5 . Hemiparesis , mainly affect upper limb ( 2 point evaluation function affect hand use test hand Frenchay 2 point evaluation affect low limb 6point scale NIHSS ) ; 6 . The time onset disease prior introduction drug 72 hour ; 7 . The willingness patient sex sexual partner preserve reproductive function use reliable method contraception , start moment inclusion study completion participation clinical study . 1 . The age 45 year old 75 year ; 2 . Known intolerance ( include allergic reaction ) Cerebrolysin , excipients investigational medication ; 3 . Thrombolytic therapy ; 4 . Signs hemorrhagic stroke ; 5 . Impairment consciousness ( ≥ 2 point evaluation item 1A NIHSS ) ; 6 . The presence element allow predict resolution neurological symptom within 24 hour first symptom ; 7 . Stroke transient ischemic attack history ; 8 . The score modify Rankin scale stroke 0 point ; 9 . Concomitant therapy neuroprotective nootropic drug ; 10 . Newonset seizures epilepsy ; 11 . Planned carotid endarterectomy operation secondary prevention stroke ; 12 . Neurological disease pathology neuromuscular system disease may affect interpretation study result ; 13 . Systemic therapy biological drug , include interferon , inductor and/or cytokine/anticytokine ( e.g. , antiTNF , antiCD4 , IL10 , IL1 , etc . ) within 1 month prior screen ; 14 . Severe concomitant disease , include cancer , , opinion investigator , may affect estimated parameter ; 15 . Uncontrolled hypertension ( SBP ≥ 220 mm Hg . CL . and/or DBP ≥ 120 mm Hg . article repeat measurement screen visit ) ; 16 . Uncontrolled angina , congestive heart failure severe arrhythmia ; 17 . The presence chronic infection ( hepatitis B , C AIDS ) active form . 18 . Severely impaired renal function hepatic impairment ( total bilirubin 1.5 hvgn , level serum creatinine 2.5 hugn level ALT , AST , GGT high 2.5 hvgn ) ; 19 . Diseases blood ; 20 . Mental illness , severe depression suicide attempt history ; 21 . The history drug addiction , alcoholism abuse drug ; 22 . Contraindications MRI : metal body , splinter , ferromagnetic implant ( pacemaker , automatic dosing drug , implant insulin pump , artificial anus magnetic closure , artificial heart valve metal element ) , steel implant ( clamps/clips blood vessel , artificial joint , metal osteosynthesis device ) , hear AIDS ; 23 . Participation clinical study within 30 day prior screen simultaneous participation clinical study ; 24 . Pregnancy , breastfeed planning pregnancy ; 25 . Women men preserve reproductive potential refuse use effective method contraception throughout study ; 26 . Life expectancy less 1 year ; 27 . Any disease circumstance , opinion investigator , may interfere subject participate study relation participation study may dangerous subject ; Premature withdrowal criterion : 1 . The research subject may discontinue participation time without give reason ; 2 . The researcher ahead time exclude patient study follow case ; 3 . The refusal subject participation study ; 4 . Failure comply subject rule participation study ; 5 . The reason emerge study threaten security subject , include associate take study medication adverse event ; 6 . The entity study pregnancy ; 7 . The application patient study period additional neuroprotective nootropic drug , drug group correctors cerebral blood flow ; 8 . Other reason arise course study prevent realization study accord Protocol ; 9 . Repeated stroke course study ; 10 . Subjects lose observation , also belong prematurely withdraw study .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Cerebrolysin</keyword>
	<keyword>neuroplasticity</keyword>
	<keyword>upper limb</keyword>
	<keyword>middle cerebral artery</keyword>
	<keyword>NBS</keyword>
	<keyword>navigation brain stimulation</keyword>
	<keyword>paretic limb</keyword>
	<keyword>stroke</keyword>
	<keyword>ischemic stroke</keyword>
	<keyword>rehabilitation</keyword>
	<keyword>Frenchay Arm Test</keyword>
	<keyword>NBS eXimia Nexstim</keyword>
	<keyword>Barthel index</keyword>
</DOC>